Public healthcare resource allocation and the Rule of Rescue
- PMID: 18591290
- DOI: 10.1136/jme.2007.021790
Public healthcare resource allocation and the Rule of Rescue
Abstract
In healthcare, a tension sometimes arises between the injunction to do as much good as possible with scarce resources and the injunction to rescue identifiable individuals in immediate peril, regardless of cost (the "Rule of Rescue"). This tension can generate serious ethical and political difficulties for public policy makers faced with making explicit decisions about the public funding of controversial health technologies, such as costly new cancer drugs. In this paper we explore the appropriate role of the Rule of Rescue in public resource allocation decisions by health technology funding advisory bodies such as the National Institute for Health and Clinical Excellence. We consider practical approaches to operationalising the Rule of Rescue from Australia and the UK before examining the relevance of individual moral imperatives to public policy making. We conclude that that whilst public policy makers in a humane society should facilitate exceptional departures from a cost effectiveness norm in clinical decisions about identified individuals, it is not so obvious that they should, as a matter of national public policy, exempt any one group of unidentified individuals within society from the rules of opportunity cost at the expense of all others.
Similar articles
-
The problem with rescue medicine.J Med Philos. 2013 Feb;38(1):64-81. doi: 10.1093/jmp/jhs056. Epub 2012 Dec 23. J Med Philos. 2013. PMID: 23267048
-
The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process.J Med Ethics. 2008 Jul;34(7):534-9. doi: 10.1136/jme.2007.021683. J Med Ethics. 2008. PMID: 18591289 Review.
-
How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.J Health Serv Res Policy. 2007 Apr;12(2):73-9. doi: 10.1258/135581907780279521. J Health Serv Res Policy. 2007. PMID: 17407655
-
Policy making and roles of health technology assessment.J Med Assoc Thai. 2008 Jun;91 Suppl 2:S88-99. J Med Assoc Thai. 2008. PMID: 19253491
-
Generalised cost-effectiveness analysis: an aid to decision making in health.Appl Health Econ Health Policy. 2002;1(2):89-95. Appl Health Econ Health Policy. 2002. PMID: 14619255 Review.
Cited by
-
Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases.J Mark Access Health Policy. 2023 Aug 10;11(1):2239557. doi: 10.1080/20016689.2023.2239557. eCollection 2023. J Mark Access Health Policy. 2023. PMID: 37583879 Free PMC article.
-
Escalating costs of innovative medicines: perspective and proposals.Front Public Health. 2024 Sep 24;12:1449707. doi: 10.3389/fpubh.2024.1449707. eCollection 2024. Front Public Health. 2024. PMID: 39381757 Free PMC article.
-
SARS-CoV-2: public health measures for managing the transition to endemicity.J R Soc Med. 2022 May;115(5):165-168. doi: 10.1177/01410768221089023. Epub 2022 Mar 31. J R Soc Med. 2022. PMID: 35357251 Free PMC article. No abstract available.
-
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare.Eur J Health Econ. 2019 Apr;20(3):427-438. doi: 10.1007/s10198-018-1007-x. Epub 2018 Sep 18. Eur J Health Econ. 2019. PMID: 30229376 Free PMC article.
-
Value judgment of health interventions from different perspectives: arguments and criteria.Cost Eff Resour Alloc. 2018 Apr 17;16:16. doi: 10.1186/s12962-018-0099-6. eCollection 2018. Cost Eff Resour Alloc. 2018. PMID: 29692687 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical